Company Search:
Advanced Search
Sponsored Links
Editas Medicine Inc Company Snapshot
Editas Medicine Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Editas Medicine Inc with three other companies in this sector in the United States: Protalix Biotherapeutics Inc (2018 sales of $34.24 million of which 100% was Biotherapeutic Products), Novavax, Inc. ($34.29 million of which 100% was Pharmaceutical Products), and Alector Inc ($27.68 million of which 100% was Biopharmacy).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Editas Medicine Inc
  Stock Performance Chart for Editas Medicine Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 30.28
(Figures in U.S. Dollars)
1 Week 24.3%   13 Weeks 40.6%  
4 Weeks 21.9%   52 Weeks -2.8%  
Editas Medicine Inc Key Data:
  Ticker: EDIT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 31,937,000
(Year Ending Jan 2019).
Employees: 133
  Currency: U.S. Dollars Market Cap: 1,546,587,275
  Fiscal Yr Ends: December Shares Outstanding: 51,076,198
  Share Type: common Closely Held Shares: 1,953,637
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.